Advertisements

Furosemid LEK

Quick links to important sections

Furosemid LEK

Advertisements
Advertisements

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Furosemid LEK

Quick Facts

Property Description
Active ingredient Furosemide (Frusemide)
Form Tablet, Oral Solution, Injectable Solution
Pharmacological class Loop Diuretic, Sulfonamide derivative
General purpose Fluid mobilization (Diuresis), Edema, Blood pressure support
Origin Synthetic chemical substance

What Type of Medicine is Furosemid LEK?

Furosemid LEK is a potent, synthetic prescription-only medicine whose active ingredient is Furosemide (Frusemide). It is chemically categorized as a sulfonamide derivative and, pharmacologically, belongs to the class of Loop Diuretics. Unlike certain alternative diuretics, this class is known for its action in the Loop of Henle, confirming its status as a potent agent in fluid management. The Furosemid LEK brand, distributed by Lek Pharmaceuticals, which operates under the Sandoz/Novartis group, adheres to strict European pharmaceutical standards.


Composition and Available Forms of Furosemid LEK

Furosemid LEK is a single active ingredient product where the core substance, Furosemide, is supplied in multiple forms to allow for flexible use, including for pediatric patients who may require the oral solution. It is available as an oral tablet and the aforementioned oral solution for standard systemic use following oral administration. It is also prepared as a sterile injectable solution (parenteral) for administration via the intravenous (IV) or intramuscular (IM) route, which is typically reserved for situations requiring immediate action. The active ingredient Furosemide is an anthranilic acid derivative, and the tablets contain various pharmaceutical excipients.


What is the General Purpose of Furosemid LEK’s Action?

The general purpose of Furosemid LEK’s action is to facilitate the swift and substantial mobilization of fluid from the body by increasing the production and flow of urine (diuresis). This is achieved by actively inhibiting the reabsorption of key electrolytes—specifically sodium and chloride—in the kidneys. This unique physiological effect is designed to reduce excess fluid accumulation, often known as edema, and its use is also beneficial in assisting the control of elevated blood pressure.

Regulatory References

  1. DailyMed Drug Information
  2. World Health Organization (WHO)
Advertisements

What side effects are possible with Furosemid LEK?

Furosemid LEK's safety profile is officially documented and classified based on the potential adverse reactions across various body systems. The classifications reflect how government regulatory documents communicate the frequency of known effects.

Frequency-Classified Adverse Reactions

The most prominent safety feature is the Very Common occurrence (affecting 1 in 10 people or more) of electrolyte and metabolic disturbances, including low levels of potassium (hypokalemia) and sodium (hyponatremia), as well as increases in blood creatinine and urea. Common effects (1 in 100 to 1 in 10 people) typically involve hypotension (low blood pressure), dizziness, and headache. Uncommon reactions include hearing disorders (ototoxicity) and skin rashes, while Rare effects (1 in 10,000 to 1 in 1,000 people) cover conditions such as leukopenia and acute pancreatitis.

Serious Adverse Reactions and Safety Constraints

The medicine is also associated with Very Rare serious adverse reactions, such as agranulocytosis (a severe drop in white blood cells) and severe anaphylactic reactions. Furthermore, severe skin conditions like Stevens-Johnson syndrome (SJS) are officially listed, though their frequency is Not Known.

Regulatory documents highlight specific safety constraints and population-related risks. The drug is contraindicated in states of anuria (absence of urine production) and severe volume depletion. Caution is necessary for patients with severe hepatic impairment due to the documented risk of hepatic coma. Additionally, the risk of ototoxicity is explicitly linked to rapid intravenous infusion and high doses, and nephrocalcinosis is a concern with long-term use in premature infants.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdosage with Furosemid LEK, a potent diuretic, results from an intensified extension of its known drug action, primarily causing excessive fluid and electrolyte loss. The most serious clinical presentations of an overdose are dehydration, blood volume reduction (hypovolemia), and severe hypotension (low blood pressure).

Clinical Manifestations of Overdose

The physiological effects of overdose are often associated with critical electrolyte imbalance, including hypokalemia (low potassium) and hypochloremic alkalosis. Symptoms may include:

  • Extreme thirst and dry mouth
  • Dizziness or confusion
  • Extreme tiredness
  • Vomiting or stomach cramps

Required Emergency Actions

Immediate medical help is required in all suspected cases of overdose. The treatment approach is supportive, focusing on the replacement of excessive fluid and electrolyte losses. Serum electrolyte levels, blood pressure, and carbon dioxide levels should be monitored frequently by healthcare professionals.

Call emergency services immediately if the person experiencing an overdose has collapsed, has trouble breathing, is having a seizure, or cannot be awakened. For patients with urinary bladder outlet obstruction, such as from an enlarged prostate, adequate urinary drainage must be maintained during the management of an overdose.

Advertisements

Therapeutic Uses of Furosemid LEK

What Furosemid LEK Treats: Main Uses and Benefits

Furosemid LEK is a medicine relevant for providing symptomatic relief across therapeutic domains where symptoms are driven by the accumulation of excess body fluid. Furosemide is indicated for the treatment of edema associated with various clinical conditions.

Symptomatic Relief and Indications

The medication is relevant for managing symptom patterns associated with conditions such as Congestive Heart Failure, liver cirrhosis, and various renal diseases. This supportive relief is particularly relevant for managing systemic and peripheral edema (swelling in the legs, ankles, and feet), ascites (abdominal fluid), and pulmonary congestion leading to shortness of breath. It is also relevant within therapeutic domains involving mild to moderate high blood pressure, particularly when volume status creates noticeable physiological strain. This supportive relief helps maintain a sense of stability when symptoms are more noticeable and disruptive. The use of Furosemid LEK provides support that helps ease the overall symptom burden and contributes to easing the overall symptom load.


Quick Fact: Relief for Congestion
Symptom Cluster Focus Symptoms related to physical discomfort and systemic burden
Conditions Relevant CHF, renal disease, liver cirrhosis, hypertension
Typical Benefit Supports the easing of physical swelling and helps address congestion symptoms
Clinical Contexts Applied in acute symptomatic episodes and chronic phases

Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Furosemid LEK?

This section outlines the official population eligibility for Furosemid LEK (Furosemide) as defined by governmental regulatory documents.


Contraindicated Populations (Must Not Use)

Furosemid LEK is contraindicated and must not be used in populations presenting with the following conditions, as these are considered absolute non-eligibility criteria:

  • Anuria (absence of urine production).
  • Known Hypersensitivity (allergy) to Furosemide or its sulfonamide-derived components.
  • States of severe fluid or electrolyte depletion, such as Severe Hypovolaemia or Severe Hypokalaemia/Hyponatraemia.
  • Hepatic Coma and pre-comatose states.

Age-Group and Condition Restrictions

Population Group Eligibility Status Regulatory Requirement
Adults and Older Adults Established Use Older adults may require a cautious, lower starting dose due to potential age-related decrease in renal function.
Pediatric Patients Established Use Use is allowed, but neonates require specific caution and monitoring for the risk of nephrocalcinosis (kidney stone formation).
Pregnancy Restricted Use Used only if the official benefit justifies the potential risk.
Lactation Not Generally Recommended Furosemide passes into breast milk and may reduce milk volume.

Conditional Use Requirements

Use of Furosemid LEK requires special caution and monitoring in patients with Severe Hepatic Impairment or Progressive Renal Disease (if not anuric). Use is also restricted in patients with conditions that may cause urinary retention, such as prostatic hypertrophy.

Advertisements

What should I know about interactions with other medicines?

The interaction profile of Furosemide is highly structured around its potential to potentiate specific toxic and hemodynamic effects when co-administered with certain substances, as documented in regulatory sources.

Interaction-Related Restrictions

The combination with ethacrynic acid is restricted due to the official documentation of additive ototoxic potential. Co-administration with aminoglycoside antibiotics is also advised to be avoided, except in severe situations, due to the increased risk of ototoxicity, especially when renal function is impaired.

Officially Documented Interaction Patterns

  • Clearance and Toxicity: Furosemide reduces the renal clearance of Lithium, leading to an increased risk of lithium toxicity. Similarly, high-dose salicylates may cause salicylate toxicity due to competitive binding at renal excretory sites.
  • Blood Pressure Potentiation: Co-administration with other antihypertensive agents, such as ACE inhibitors or ARBs, carries an official risk of severe hypotension and potential deterioration in renal function. Alcohol, barbiturates, or narcotics may also aggravate orthostatic hypotension.
  • Reduced Effectiveness/Absorption: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may officially antagonize the diuretic effect and increase the risk of nephrotoxicity. Sucralfate decreases the absorption of oral Furosemide, necessitating that its administration be separated by at least two hours.
  • Electrolyte Risk: Substances such as Corticosteroids and large amounts of Licorice increase the risk of hypokalemia (low potassium) due to an additive electrolyte-wasting effect.
  • Population-Specific: A higher incidence of mortality was observed in elderly patients with dementia when Furosemide was co-administered with Risperidone, according to regulatory documentation.
Advertisements

Mechanism of Action

Specific Blockade of the Renal Salt Transporter

The mechanism begins with the specific and competitive inhibition of the Sodium-Potassium-Chloride Cotransporter 2 ( NKCC2), a protein located in the thick ascending limb of the kidney's loop structure. Blocking this transporter physically stops the reabsorption of essential salts ( sodium, chloride, and potassium) from the forming urine back into the bloodstream. This targeted action directly influences the renal ion transport pathway, which is essential for maintaining the body's normal fluid retention.


Causal Cascade Leading to Diuresis

The failure to reabsorb these large quantities of solutes disrupts the natural osmotic gradient within the kidney. This disruption prevents water from being passively drawn out of the urine-forming tubules, resulting in a large volume of water being retained in the fluid. This mechanistic cascade leads directly to a substantial increase in the production and excretion of water, resulting in substantial diuresis and a decrease in total extracellular fluid volume.


Physiological Limitations and Flow Effects

The strong primary mechanism creates secondary physiological effects, such as the accelerated loss of potassium and other electrolytes due to the high flow rate of fluid through the distal tubule. The action is subject to a physiological constraint known as the Braking Phenomenon, involving an adaptive increase in the salt-reabsorbing capacity of the subsequent distal nephron segments.

Advertisements

Dosage and Administration Information

Official Administration Guidelines for Furosemid

Furosemide (Furosemid) is administered via several approved routes and dosage forms, with usage guided by established medical protocols.

Administration Scope Official Instruction Summary
Route of Administration Oral (tablet, solution), Intravenous (IV) injection or infusion, and Intramuscular (IM) injection. Parenteral use is generally reserved for emergency situations or when oral intake is not feasible.
Standard Dosing Schedule Adult Oral: Initial dose is typically 20 mg to 80 mg as a single daily dose. This dose may be repeated or increased by 20 mg to 40 mg not sooner than 6 to 8 hours after the previous dose. Adult IV/IM: Initial dose is typically 20 mg to 40 mg, which can be repeated after 2 hours if needed.
Frequency and Timing Oral administration is typically once or twice daily, preferably given in the morning to avoid nocturnal diuresis. The single dose that achieves the desired effect is then used for maintenance.
Preparation & Conditions IV injections must be administered slowly over 1 to 2 minutes. High-dose IV therapy requires controlled infusion at a rate not exceeding 4 mg per minute in adults. Oral forms can be taken with or without food.
Age-Group Rules Pediatric dosing is calculated based on body weight (typically starting at 1 mg/kg or 2 mg/kg orally). Geriatric patients require cautious dose selection, usually starting at the low end of the adult dosing range due to slower elimination.

The official protocol dictates that intravenous administration should be switched to oral therapy as soon as clinically practical. Dosing must always be individualized to the patient's specific needs, and subsequent doses (both oral and parenteral) are spaced by defined time intervals to avoid rapid or excessive diuresis, adhering precisely to the standardized sequence of use.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of studies for Furosemid LEK

Evidence for use in Edema and Volume Overload

The research base for Furosemid LEK (Furosemide) for managing fluid accumulation has been the subject of a large volume of research. Studies have focused on conditions like Congestive Heart Failure (CHF), various forms of kidney disease, and liver cirrhosis, which are conditions characterized by fluctuating or episodic manifestations of fluid retention. Research explored short-term changes in patients experiencing periods of heightened symptom activity, such as acute fluid buildup.

The available research is built largely on Randomized Controlled Trials (RCTs), often summarized by Meta-analyses. Furosemide was studied in trials that monitored fluid loss and systemic or functional imbalance. Studies monitored objective outcomes, including urine output, natriuresis (the amount of salt excreted in the urine), and changes in body weight. Researchers also applied studies examining patient-reported experiences, tracking outcomes related to physical discomfort and functional capacity.

Findings describe patterns related to fluid excretion following administration, and studies monitored related changes in physical signs of congestion across a broad range of adult populations with varying degrees of disease severity. Some comparative trials reported patterns where outcomes related to rehospitalization and survival varied when Furosemide was evaluated alongside certain alternative loop diuretics. However, long-term effects are not fully established regarding patient survival or re-admission rates for all studied groups.


Evidence for use in Elevated Blood Pressure (Hypertension)

Research examining the use of Furosemid LEK for elevated blood pressure has been conducted, primarily through Randomized Controlled Trials and systematic reviews that compared it against other blood pressure medications. This evidence explores short-term symptom changes, focusing on conditions associated with acute or disruptive episodes of high blood pressure, especially those linked to increased volume.

The outcomes related to monitoring physiological strain or stress were central, with studies monitored Systolic and Diastolic Blood Pressure. Findings describe patterns related to blood pressure reduction, particularly in populations where the high blood pressure was associated with volume overload or significant kidney impairment. Research examined whether the duration of the blood pressure-related effect is shorter compared to other diuretic types used for long-term management. Research also describes that the measured change in blood pressure may be more pronounced in patients with Chronic Kidney Disease compared to those with uncomplicated hypertension, as results apply only to the specific populations studied.


Understanding Research Limitations and Uncertainties

Research provides context but not individual predictions, and evidence highlights what is known—and what is still uncertain. One key area of uncertainty relates to the variable oral absorption of Furosemid LEK, particularly in patients with significant existing edema, which can cause inconsistent fluid management.

Long-term outcomes were not consistently established across comparative studies involving other therapies. Research limitations include that the results apply only to the specific populations studied, meaning the applicability of findings to patients with very different underlying conditions is uncertain. Research is ongoing to better understand these areas.

Key Studies & References

  1. Furosemide Tablet and Injectable Solution (DailyMed Drug Information)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Furosemid LEK (FAQ)


Q: Is Furosemid LEK considered a water pill?

Furosemide is classified by official regulatory sources as a loop diuretic. This type of medicine, which promotes the flow of urine, is commonly referred to in accessible language as a 'water pill.'


Q: How quickly should I expect Furosemid LEK to start working after taking it?

According to regulatory documentation, the onset of action depends on the route of administration. The diuretic effect of the oral form typically begins within about one hour, while the intravenous form starts working within minutes.


Q: How long does the effect of Furosemid LEK typically last?

Official product information indicates that the therapeutic effect of the oral form typically lasts for about six to eight hours. The effect of the intravenous administration is shorter.


Q: What is the difference between Furosemid LEK and other common diuretics?

Furosemid LEK is categorized as a Loop Diuretic because its action is specific to the loop of Henle in the kidney. This specific site of action (loop of Henle) is associated with a greater fluid-mobilizing capacity compared to diuretics that act on the distal tubule, such as thiazide diuretics.


Q: Can Furosemid LEK cause dehydration, and what are the signs?

Furosemide may cause dehydration, or volume depletion, due to its potent fluid-removing action. Signs of volume depletion listed in regulatory documents may include unusual thirst, dry mouth, weakness, dizziness when standing, or muscle cramps.


Q: Are there any common foods or supplements that should be avoided with Furosemid LEK?

Regulatory documents indicate that co-administration with large amounts of Licorice is associated with an increased risk of low potassium (hypokalemia). Additionally, the absorption of the oral form is decreased by Sucralfate, requiring at least a two-hour separation in administration.


Q: Why do some people call Furosemid LEK by the name Lasix?

Furosemide is the established name for the active substance in Furosemid LEK. The name Lasix is a common brand name under which the drug is marketed in certain countries, which is why the names are often used interchangeably.


Q: Is there any restriction on driving or operating machinery while taking this medicine?

Due to potential side effects like dizziness or low blood pressure, regulatory warnings state that activities requiring full attention, such as driving or operating heavy machinery, should be avoided until the medicine's effect on the individual is fully known.


Q: Are there any known long-term effects of taking Furosemid LEK for years?

Official safety documents indicate that prolonged or repeated exposure to Furosemide has been associated with damage to the kidneys and liver. Long-term use may also lead to a risk of developing low magnesium levels (hypomagnesemia).


Q: Can Furosemid LEK be used by people with kidney problems?

Furosemide is indicated for use in managing fluid retention (edema) associated with certain kidney diseases. However, regulatory documents strictly prohibit its use if there is a complete absence of urine production (anuria).


Q: What are the serious signs of an allergic reaction to Furosemid LEK?

Serious allergic reactions, though rare, are described in official safety documents. These reactions may manifest as a severe rash, blistering of the skin, hives, swelling of the face, tongue, or throat, or difficulty breathing.


Q: Can people with diabetes use Furosemid LEK?

Official product information indicates that Furosemide may cause an increase in blood sugar levels (hyperglycemia). Regulatory documents mention that changes in anti-diabetic medication may be necessary.


Q: Are there different strengths of Furosemid LEK tablets available?

According to official drug information, Furosemide oral tablets are available in several dosage strengths. These typically include 20 mg, 40 mg, and 80 mg tablets.


Q: What is the relationship between Furosemid LEK and Gout?

Regulatory documents state that Furosemide can lead to an increase in uric acid levels in the blood (hyperuricemia). This effect may potentially trigger or exacerbate attacks of gout.


Q: Can Furosemid LEK cause sun sensitivity or a rash when exposed to sunlight?

Official warnings indicate that Furosemide may cause the skin to become more sensitive to sunlight (photosensitivity). Skin rashes are also listed as an uncommon adverse reaction associated with this medicine.


Q: Is Furosemid LEK used to treat all types of heart failure?

Furosemide is indicated for managing fluid accumulation (edema) associated with Congestive Heart Failure (CHF). Official indications do not explicitly list all types of heart failure.


Q: Can people with liver cirrhosis take Furosemid LEK?

Furosemide is indicated for managing edema associated with liver cirrhosis. However, its use is strictly contraindicated in patients experiencing hepatic coma or pre-comatose states.


Q: Are there any known interactions with herbal supplements and Furosemid LEK?

Regulatory documents indicate that combining Furosemide with large amounts of Licorice is associated with an increased risk of low potassium (hypokalemia). Information on other common herbal supplements is not explicitly covered in official drug labels.


Q: What is the typical time frame for reaching the full effect of Furosemid LEK in fluid removal?

Official pharmacokinetics data indicates that the maximum or 'peak' fluid-mobilizing effect of an oral dose typically occurs within 1 to 1.5 hours after administration.


Q: How does Furosemid LEK compare to hydrochlorothiazide in terms of how it works?

Regulatory documents describe Furosemide as a Loop Diuretic that works in the loop of Henle, reflecting its classification as a Loop Diuretic. This contrasts with hydrochlorothiazide, which acts on the distal tubule and is classified differently.


Q: Can taking Furosemid LEK cause stomach upset or nausea?

Official safety documents list nausea and vomiting as uncommon adverse reactions that may occur. Other possible gastrointestinal effects include stomach irritation or cramping.


Q: What happens if I stop taking Furosemid LEK suddenly?

Furosemide works to swiftly remove excess fluid from the body. Abrupt discontinuation would stop the diuretic action, and this is associated with the potential for the rapid return of fluid accumulation (edema) or an increase in blood pressure.


Q: Is it possible for Furosemid LEK to increase blood sugar levels?

Yes, official safety documents list high blood sugar (hyperglycemia) and sugar in the urine (glycosuria) as potential adverse reactions associated with Furosemide use.


Q: Are there any dietary restrictions generally associated with taking Furosemid LEK?

Regulatory documents state that Furosemide can be taken with or without food. The main dietary consideration mentioned is avoiding substances like Licorice that are known to contribute to electrolyte loss.


Q: Why is Furosemid LEK sometimes described as a 'high-ceiling' diuretic?

Furosemide is referred to as a 'high-ceiling' diuretic because it is a potent medicine. This classification indicates that it is capable of inducing a profound and substantial increase in urine flow (diuresis).


Q: Does Furosemid LEK affect the body's magnesium levels?

Yes, official safety documents indicate that Furosemide may cause a reduction in the body's magnesium levels, a condition known as hypomagnesemia, as a potential adverse effect.


Q: Can Furosemid LEK cause muscle cramps?

Muscle cramps or muscle spasm are listed in official regulatory documents as potential adverse reactions. These symptoms are often related to the electrolyte disturbances the medicine can cause.

Advertisements

How should Furosemid LEK be stored and disposed of?

How to Store and Dispose of Furosemid LEK?

This section outlines the official, regulator-mandated conditions for storing and disposing of Furosemid LEK (Furosemide).

Storage Requirements

Furosemid LEK must be stored out of the sight and reach of children.

Condition Tablets Injectable Solution
Temperature Does not require special conditions. Must not be stored above 25 °C.
Container Keep in the original package to protect from moisture. Keep in the original package to protect from light.
Prohibited Keep from freezing. Do not refrigerate or freeze.
Stability N/A Use immediately after first opening.

Disposal Instructions

Any unused or expired product must be disposed of in accordance with local regulations. It is strictly mandated that the medicine must not be thrown away via wastewater or flushed down the toilet. Consult a pharmacist for information on medicine take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Furosemid LEK found in:

A-Z Index: